Latest news and stories about patient care in technology in Lisboa, Portugal for expats and residents.
The Santa Maria Local Health Unit is expected to launch a revised tender for the USF Lumiar project, aiming to address the needs of 8,000 patients currently lacking a family doctor.
Artificial intelligence is revolutionising tuberculosis diagnosis by enabling rapid identification via chest X-rays, helping to combat the disease's stigma and improve early intervention for respiratory conditions.
Ten years ago, Garcia de Orta Hospital in Almada opened the first hospital-at-home unit. Today there are already 50 Local Health Units offering this service — a way of delivering healthcare to 400 patients receiving inpatient care outside the hospital.
There is a decisive scientific discovery for those facing the most aggressive form of skin cancer: melanoma. It is an experimental vaccine that is personalised for each person's tumour. Three of the patients in this international clinical trial are being monitored at the IPO in Lisbon.
This is another technological advancement in healthcare. The Lisbon IPO performed the first lung cancer diagnostic exam using a robot. It allows for earlier diagnosis, greater precision, less patient suffering, and better treatment prospects.
The impact of technology on the competitiveness and cybersecurity of Portuguese companies was the theme of the second edition of the Vodafone Open Day, which took place this Thursday at Taguspark in Oeiras. At the event, which brought together clients and partners, the multinational presented three new services, one of which is the Care Tracker, which allows for the remote monitoring of seniors and those under medical supervision.
Empathy, ethics, the integration of public, social, and private systems, and the benefits of using artificial intelligence in healthcare were the main topics at the DN Grand Conference. Experts discussed how digital transition is vital, yet AI cannot replace the 'human doctor' or the essential role of empathy in patient care. The panel also addressed the need for better health literacy, the importance of investment in increasingly expensive medical technologies, and the necessity for interoperable data systems across hospitals.
Over the last three years, Infarmed has authorised 591 new clinical trials, one-third of which are in the field of cancer.
Lisbon hosted the URONEXT forum, where surgeons demonstrated the Renal Sutureless Device (RSD) technique. By using a 3D-printed, biocompatible haemostatic mould instead of traditional internal stitches, the procedure reduces trauma to healthy kidney tissue, improves recovery times, and protects long-term cardiovascular health.
